Ricci S. Whitlow serves as the Executive Vice President and Chief Operating Officer at MiMedx Group, Inc., a leading biopharmaceutical company specializing in the development and commercialization of regenerative medicine products. In her role, Whitlow is responsible for overseeing the company's operational strategies, ensuring efficient and effective execution of business plans, and driving growth and innovation within the organization. Her leadership has been instrumental in streamlining processes and enhancing the company's ability to deliver high-quality products to patients in need. Whitlow brings a wealth of experience to her position at MiMedx, with a strong background in the healthcare and pharmaceutical industries. Prior to joining MiMedx, she held various leadership positions at prominent companies, where she demonstrated her ability to navigate complex challenges and drive successful outcomes. Her expertise in operations management, strategic planning, and team development has been a key factor in her success and has earned her a reputation as a respected leader in the industry. Throughout her career, Whitlow has been recognized for her achievements and contributions to the field of regenerative medicine. She has played a pivotal role in advancing MiMedx's mission to improve patient outcomes through innovative therapies and has been instrumental in the company's growth and expansion. Under her guidance, MiMedx has continued to solidify its position as a leader in the industry, and Whitlow's dedication to excellence and her passion for improving patient care have made her an invaluable asset to the organization.